A repurposed epilepsy drug called sultiame cut breathing interruptions during sleep by up to 50% in adults with moderate-to-severe obstructive sleep apnea, according to results from a major European ...

A once-daily pill called sulthiame cut breathing interruptions during sleep by up to 47 percent in adults with obstructive ...

Millions of people in the U.S. have sleep apnea, most of whom aren’t getting treated for it. But a simple daily pill of an ...

A European clinical trial found that the drug sulthiame significantly reduced breathing interruptions in people with moderate to severe sleep apnea. Patients taking higher doses experienced up to 47% ...

Scientists say the combination of insomnia and sleep apnea could quietly increase the risk of heart disease. New research ...

A European clinical trial found that sulthiame, a drug used in the treatment of epilepsy, reduced breathing interruptions.

Researchers at Yale School of Medicine (YSM) are drawing attention to a powerful and preventable factor in cardiovascular disease. Their findings suggest that improving sleep may play a much ...

The FDA recently approved the first drug specifically for treating moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity: tirzepatide (Zepbound). The approval was based on results of ...

When you think of people with sleep apnea, maybe you picture loud, cartoonish snoring, or assume you’d know something was wrong because you’d wake up feeling completely wiped out every morning. But ...

Matt Fuchs lives in Maryland and writes about health, science, and technology. Matt Fuchs lives in Maryland and writes about health, science, and technology. As a young physician in Sydney, Australia ...

Chronic obstructive pulmonary disease (COPD) is known for causing breathing difficulties and limiting everyday activities. Obstructive sleep apnea syndrome (OSAS), on the other hand, is usually ...